ESLOY vs. NVO
ESLOY (Essilor International SA) and NVO (Novo Nordisk A/S) are both stocks. Both are in the Healthcare sector — ESLOY in Medical Instruments & Supplies, NVO in Drug Manufacturers - General. Over the past 10 years, ESLOY returned 5.92%/yr vs 6.21%/yr for NVO. At a 0.33 correlation, their price movements are largely independent.
Performance
ESLOY vs. NVO - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, ESLOY achieves a -36.56% return, which is significantly lower than NVO's -14.57% return. Both investments have delivered pretty close results over the past 10 years, with ESLOY having a 5.92% annualized return and NVO not far ahead at 6.21%.
ESLOY
- 1D
- -0.92%
- 1M
- -1.41%
- YTD
- -36.56%
- 6M
- -44.28%
- 1Y
- -27.89%
- 3Y*
- 4.31%
- 5Y*
- 4.22%
- 10Y*
- 5.92%
NVO
- 1D
- -2.14%
- 1M
- -5.38%
- YTD
- -14.57%
- 6M
- -8.62%
- 1Y
- -38.01%
- 3Y*
- -16.72%
- 5Y*
- 2.89%
- 10Y*
- 6.21%
ESLOY vs. NVO - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
ESLOY Essilor International SA | -36.56% | 33.44% | 22.45% | 12.96% | -13.84% | 38.51% | 2.43% | 23.58% | -7.18% | 26.94% |
NVO Novo Nordisk A/S | -14.57% | -39.22% | -15.93% | 54.84% | 22.66% | 63.52% | 23.33% | 28.70% | -12.98% | 52.92% |
Correlation
The correlation between ESLOY and NVO is 0.21, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.21 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.20 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.27 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.28 |
Correlation (All Time) Calculated using the full available price history since Jul 16, 2007 | 0.33 |
The correlation between ESLOY and NVO shifts across timeframes, from 0.20 (3 years) to 0.33 (all time), reflecting how their relationship changes across market environments.
Fundamentals
ESLOY:
$92.20B
NVO:
$186.85B
ESLOY:
$5.01
NVO:
$27.42
ESLOY:
19.60
NVO:
1.53
ESLOY:
1.65
NVO:
0.07
ESLOY:
1.67
NVO:
0.57
ESLOY:
2.37
NVO:
0.92
ESLOY:
$54.89B
NVO:
$327.80B
ESLOY:
$33.87B
NVO:
$268.30B
ESLOY:
$12.51B
NVO:
$181.54B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
ESLOY vs. NVO — Risk / Return Rank
ESLOY
NVO
ESLOY vs. NVO - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Essilor International SA (ESLOY) and Novo Nordisk A/S (NVO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| ESLOY | NVO | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.12 | ||
| Sortino ratioReturn per unit of downside risk | -0.42 | ||
| Omega ratioGain probability vs. loss probability | 0.85 | 0.88 | -0.03 |
| Calmar ratioReturn relative to maximum drawdown | -0.61 | -0.69 | +0.09 |
| Martin ratioReturn relative to average drawdown | -1.27 | -1.03 | -0.24 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| ESLOY | NVO | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | -0.86 | -0.74 | -0.12 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.15 | 0.08 | +0.07 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.22 | 0.19 | +0.03 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.13 | 0.47 | -0.34 |
Drawdowns
ESLOY vs. NVO - Drawdown Comparison
The maximum ESLOY drawdown since its inception was -74.27%, roughly equal to the maximum NVO drawdown of -74.70%. Use the drawdown chart below to compare losses from any high point for ESLOY and NVO.
Loading charts...
Drawdown Indicators
| ESLOY | NVO | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -74.27% | -74.70% | +0.43% |
Max Drawdown (1Y)Largest decline over 1 year | -46.23% | -55.03% | +8.80% |
Max Drawdown (3Y)Largest decline over 3 years | -46.23% | -74.70% | +28.47% |
Max Drawdown (5Y)Largest decline over 5 years | -46.23% | -74.70% | +28.47% |
Max Drawdown (10Y)Largest decline over 10 years | -46.23% | -74.70% | +28.47% |
Current DrawdownCurrent decline from peak | -45.86% | -69.48% | +23.62% |
Average DrawdownAverage peak-to-trough decline | -21.00% | -17.76% | -3.24% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 22.04% | 36.88% | -14.84% |
Volatility
ESLOY vs. NVO - Volatility Comparison
The current volatility for Essilor International SA (ESLOY) is 6.79%, while Novo Nordisk A/S (NVO) has a volatility of 7.84%. This indicates that ESLOY experiences smaller price fluctuations and is considered to be less risky than NVO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| ESLOY | NVO | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 6.79% | 7.84% | -1.05% |
Volatility (6M)Calculated over the trailing 6-month period | 25.90% | 37.83% | -11.93% |
Volatility (1Y)Calculated over the trailing 1-year period | 32.55% | 51.76% | -19.21% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 28.16% | 38.21% | -10.05% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 27.16% | 32.49% | -5.33% |
Dividends
ESLOY vs. NVO - Dividend Comparison
ESLOY's dividend yield for the trailing twelve months is around 2.39%, less than NVO's 4.29% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
ESLOY Essilor International SA | 2.39% | 1.42% | 1.75% | 1.76% | 1.46% | 0.62% | 0.90% | 1.49% | 1.49% | 3.64% | 2.21% | 0.91% |
NVO Novo Nordisk A/S | 4.29% | 3.31% | 1.68% | 1.00% | 1.20% | 1.35% | 1.87% | 2.14% | 1.45% | 1.52% | 2.87% | 0.92% |
Financials
ESLOY vs. NVO - Financials Comparison
This section allows you to compare key financial metrics between Essilor International SA and Novo Nordisk A/S. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
ESLOY vs. NVO - Profitability Comparison
ESLOY - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Essilor International SA reported a gross profit of 8.35B and revenue of 14.36B. Therefore, the gross margin over that period was 58.2%.
NVO - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Novo Nordisk A/S reported a gross profit of 83.23B and revenue of 96.82B. Therefore, the gross margin over that period was 86.0%.
ESLOY - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Essilor International SA reported an operating income of 1.36B and revenue of 14.36B, resulting in an operating margin of 9.5%.
NVO - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Novo Nordisk A/S reported an operating income of 59.62B and revenue of 96.82B, resulting in an operating margin of 61.6%.
ESLOY - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Essilor International SA reported a net income of 921.13M and revenue of 14.36B, resulting in a net margin of 6.4%.
NVO - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Novo Nordisk A/S reported a net income of 48.56B and revenue of 96.82B, resulting in a net margin of 50.2%.
Frequently Asked Questions
ESLOY and NVO have a correlation of 0.21, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
NVO has higher volatility (7.84%) compared to ESLOY (6.79%). In terms of maximum drawdown, ESLOY dropped -74.27% vs NVO's -74.70%.
NVO currently has the higher Sharpe Ratio (-0.74 vs -0.86), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for ESLOY and NVO
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer